DENAS, GENTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.119
AS - Asia 2.642
EU - Europa 1.046
SA - Sud America 485
AF - Africa 386
Continente sconosciuto - Info sul continente non disponibili 82
OC - Oceania 29
Totale 9.789
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.888
SG - Singapore 811
VN - Vietnam 512
CN - Cina 481
BR - Brasile 309
HK - Hong Kong 247
IT - Italia 145
DE - Germania 131
SE - Svezia 85
FI - Finlandia 84
FR - Francia 76
GB - Regno Unito 67
IN - India 61
NL - Olanda 56
JP - Giappone 53
BD - Bangladesh 46
RU - Federazione Russa 45
PL - Polonia 44
AR - Argentina 43
CA - Canada 42
IQ - Iraq 42
TR - Turchia 32
CI - Costa d'Avorio 28
PH - Filippine 26
EC - Ecuador 25
MX - Messico 24
AT - Austria 23
PK - Pakistan 23
ZA - Sudafrica 23
BE - Belgio 22
IE - Irlanda 22
VE - Venezuela 22
CO - Colombia 21
UA - Ucraina 20
ID - Indonesia 19
SA - Arabia Saudita 19
EG - Egitto 18
ES - Italia 18
JM - Giamaica 17
RO - Romania 17
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
NP - Nepal 16
PY - Paraguay 16
CY - Cipro 15
MA - Marocco 15
KE - Kenya 14
LA - Repubblica Popolare Democratica del Laos 14
CR - Costa Rica 13
KG - Kirghizistan 13
MW - Malawi 13
PA - Panama 13
PE - Perù 13
TH - Thailandia 13
TW - Taiwan 13
BA - Bosnia-Erzegovina 12
BY - Bielorussia 12
DO - Repubblica Dominicana 12
KZ - Kazakistan 12
LB - Libano 12
MD - Moldavia 12
MG - Madagascar 12
MY - Malesia 12
PT - Portogallo 12
TJ - Tagikistan 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
CM - Camerun 11
DZ - Algeria 11
HN - Honduras 11
IL - Israele 11
JO - Giordania 11
ML - Mali 11
SN - Senegal 11
SO - Somalia 11
XK - ???statistics.table.value.countryCode.XK??? 11
BJ - Benin 10
CH - Svizzera 10
CU - Cuba 10
GR - Grecia 10
MZ - Mozambico 10
NI - Nicaragua 10
PR - Porto Rico 10
UY - Uruguay 10
YE - Yemen 10
YT - Mayotte 10
AM - Armenia 9
AZ - Azerbaigian 9
DJ - Gibuti 9
ET - Etiopia 9
GA - Gabon 9
GN - Guinea 9
GP - Guadalupe 9
HR - Croazia 9
KR - Corea 9
NG - Nigeria 9
TN - Tunisia 9
ZW - Zimbabwe 9
AL - Albania 8
AO - Angola 8
Totale 9.366
Salva come PNG Salva come JPEG
Città #
Ashburn 644
Fairfield 613
San Jose 515
Singapore 502
Woodbridge 319
Chandler 318
Houston 245
Ann Arbor 243
Cambridge 233
Hong Kong 223
Seattle 199
Wilmington 185
Ho Chi Minh City 144
Beijing 121
Hanoi 115
Santa Clara 91
Los Angeles 83
Boardman 69
New York 60
San Diego 50
Princeton 48
Munich 47
Medford 45
Helsinki 43
Des Moines 41
Lauterbourg 40
Tokyo 35
Bytom 32
Frankfurt am Main 32
Nanjing 29
Abidjan 28
Dong Ket 27
Buffalo 24
Da Nang 24
Baghdad 21
Orem 21
Padova 21
Chicago 20
Dublin 19
Redondo Beach 18
Guangzhou 17
Haiphong 17
Roxbury 17
São Paulo 16
Chennai 15
Milan 15
Tashkent 15
Brooklyn 13
Cairo 13
Johannesburg 13
Panama City 13
Vienna 13
Vientiane 13
Bishkek 12
Denver 12
London 12
Montreal 12
Nanchang 12
Shenyang 12
Toronto 12
Bamako 11
Biên Hòa 11
Dakar 11
Dallas 11
Dushanbe 11
Hải Dương 11
Kingston 11
Stockholm 11
Amman 10
Antananarivo 10
Boston 10
Brussels 10
Caracas 10
Istanbul 10
Managua 10
Nairobi 10
Phoenix 10
Turku 10
Warsaw 10
Atlanta 9
Baku 9
Bangkok 9
Can Tho 9
Conakry 9
Cotonou 9
Guayaquil 9
Harare 9
Hefei 9
Libreville 9
Minsk 9
Nuremberg 9
Pristina 9
San José 9
Yerevan 9
Addis Ababa 8
Bắc Ninh 8
Dar es Salaam 8
Falkenstein 8
Gaborone 8
Havana 8
Totale 6.242
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 333
Laboratory testing for antiphospholipid syndrome 288
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 281
Antiphospholipid syndrome and the heart: A case series and literature review 272
Dyspnoea in a young woman: the opposite of every truth is just as true 271
Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation 268
Reference values for 3D echo parameters describing left ventricular mechanics obtained by vendor-independent software 266
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles 261
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns 259
APS - Diagnostics and challenges for the future 254
The Paradox of the Lupus Anticoagulant: History and Perspectives 250
Diagnosis and therapy of antiphospholipid syndrome 247
The benefit of betrixaban for the extended thromboprophylaxis in acutely ill medical patients 247
Laboratory Diagnostics of Antiphospholipid Syndrome 245
Lupus anticoagulant testing: Diluted Russell Viper Venom Time (dRVVT) 231
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk 227
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome. 227
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant 222
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial 218
One-Year Outcomes After Transapical Echocardiography-Guided Mitral Valve Repair 218
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study 217
A Bridging Protocol in High-Thrombotic Risk Mechanical Valve Bearers Undergoing Surgery or Invasive Procedures 213
Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective 212
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with Antiphospholipid Syndrome: a nationwide survey 211
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study 211
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation 207
An unusual acute coronary syndrome: undisclosed disease hidden under a confounding clinical presentation 202
An Approach to Differential Diagnosis of Antiphospholipid Antibody Syndrome and Related Conditions 198
The role of platelets in antiphospholipid syndrome 196
Interpretation of laboratory data and need for reference laboratories. 195
Correct laboratory approach to APS diagnosis and monitoring 193
Relationship of 3D left ventricular mass with systolic and diastolic function indices in hypertrophic cardiomyopathy 191
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma 188
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 184
Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis 184
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure. 180
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study 178
To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort 176
Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study 175
Secondary prevention in thrombotic antiphospholipid syndrome. 172
Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy 172
Optimizing quality care for the oral vitamin K antagonists (VKAs) 170
Normal left ventricular mechanics by two-dimensional speckle-tracking echocardiography. Reference values in healthy adults 162
Reference values of right ventricular longitudinal strain by speckle tracking echocardiography in 219 healthy volunteers 162
Investigational anticoagulants for hematological conditions: a new generation of therapies 155
Totale 9.789
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.830
article - articoli 27.830
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022673 0 70 89 52 17 48 41 80 29 16 59 172
2022/2023557 116 67 15 74 84 63 2 40 53 4 33 6
2023/2024218 7 34 25 22 7 34 14 27 5 5 19 19
2024/20251.170 6 81 72 47 139 14 93 103 83 30 192 310
2025/20264.685 243 374 543 674 440 188 835 341 578 241 146 82
2026/2027168 148 20 0 0 0 0 0 0 0 0 0 0
Totale 9.789